Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1965 1
1973 1
1975 1
2019 1
2020 1
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
First-line pazopanib in intermediate- and poor-risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trial.
Staehler M, Panic A, Goebell PJ, Merling M, Potthoff K, Herrmann E, de Geeter P, Vannier C, Hogrefe C, Marschner N, Grünwald V. Staehler M, et al. Among authors: merling m. Int J Cancer. 2021 Feb 15;148(4):950-960. doi: 10.1002/ijc.33238. Epub 2020 Aug 18. Int J Cancer. 2021. PMID: 32738823 Free article. Clinical Trial.
The treatment with L-dopa and amantadine in Parkinson's disease.
Pendefunda G, Pollingher B, Stefanache F, Gavril A, Oprisan C, Merling M, Nemteanu E, Ciunru M, Koropitzer I. Pendefunda G, et al. Among authors: merling m. Ther Hung. 1975;23(1):12-6. Ther Hung. 1975. PMID: 1105871 Clinical Trial. No abstract available.
[Treatment of the parkinsonian syndrome with L-dopa and amantadine].
Pendefunda GH, Pollingher B, Stefanache F, Gavril A, Oprişan C, Merling M, Nemţeanu E, Ciuntu M, Koropitzer I. Pendefunda GH, et al. Among authors: merling m. Neurol Psihiatr Neurochir. 1973 Nov-Dec;18(6):559-68. Neurol Psihiatr Neurochir. 1973. PMID: 4790488 Romanian. No abstract available.
[Research on environmental conditions and on occupational pathology of Anopheles eradicators. Chronic poisoning by hexachlorocyclohexane (H.C.H.). II. Clinical modifications caused by the action of H.C.H. on Anopheles eradicators].
WASSERMANN M, PENDEFUNDA G, MERLING M, MIHAIL G, SANDULESCU G, VANCEA G. WASSERMANN M, et al. Among authors: merling m. Arch Mal Prof. 1961 Jun-Jul;22:308-17. Arch Mal Prof. 1961. PMID: 13783313 French. No abstract available.